Piper Sandler Maintains Overweight on Stryker, Lowers Price Target to $390
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice TargetHot
Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $420 to $390.
Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $420 to $390.